Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells

Acta Pharmaceutica

Volumn 62, Issue 1, 2012, Pages 83-92

  Mohammadi, Zohreh ^a,b   Dorkoosh, Farid Abedin ^a   Hosseinkhani, Saman ^c   Amini, Tina ^d   Rahimi, Amir Abbas ^e   Najafabadi, Abdolhossein Rouholamini ^a   Tehrani, Morteza Rafiee ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AVICENNA RESEARCH INSTITUTE   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

^d Nobleceuticals Ltd   (United Kingdom)

^e PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

chitosan; FAP B; gene delivery; nanoparticle; stability

Indexed keywords

CHITOSAN DNA FAP B NANOPARTICLE; NANOCARRIER; PLASMID DNA; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL CULTURE; DNA BINDING; DNA PURIFICATION; DRUG STABILITY; GENE AMPLIFICATION; GENETIC TRANSFECTION; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; NONVIRAL GENE DELIVERY SYSTEM; SHELF LIFE; STORAGE TEMPERATURE; SYNTHESIS; ZETA POTENTIAL;

EID: 84859472287     PISSN: 13300075     EISSN: 18469558     Source Type: Journal    
DOI: 10.2478/v10007-012-0008-z     Document Type: Article

References (18)

1. S. Mansouria, Y. Cuieb, F. Winnikb, Q. Shia, P. Lavignea, M. Benderdoura, E. Beaumonta and J. C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy, Bioma-terials 27 (2006) 2060-2065; DOI: 10.1016/j.biomaterials.2005.09.020. (Pubitemid 41759500)
2. Z. Cui and R. J. Mumper, Chitosan-based nanoparticles for topical genetic immunization, J. Control. Release 75 (2001) 409-419; DOI: 10.1016/s0168- 3659(01)00407-2. (Pubitemid 32727270)
3. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe and A. P. Ro-lland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plas-mid delivery, J. Control. Release 56 (1998) 259-272; DOI: 10.1016/s0168-3659(98)00097-2. (Pubitemid 28511146)
4. S. Safari, F. A. Dorkoosh, M. Soleimani, M. H. Zarrintan, H. Akbari, B. Larijani and M. Rafiee Tehrani, N-Diethylmethyl chitosan for gene delivery to pancreatic cancer cells and the relation between charge ratio and biologic properties of polyplexes via interpolations polynomial, Int. J. Pharm. 420 (2011) 350-357; DOI: 10.1016/j.ijpharm.2011.08.050.
5. M. Abolhassani, M. Lagranderie, I. Caminshi, F. Romain, A. Balazuc, M. Wagner, M. Tanguy, L. Fiette, I. Sobhani, G. Milon and G. Marchal, Similar functional activity of dendritic cells recruited to the mesenteric lymph nodes of newborn and adult mice after the rectal delivery of Myco-bacterium bovis BCG, Microbes Infect 8 (2006) 2341-2351; DOI: 10.1016/j.micinf.2006.03.022. (Pubitemid 44499048)
6. Z. Mohammadi, M. Abolhassani, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rou-holamini Najafabadi and M. Rafiee Tehrani, Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells, Int. J. Pharm. 409 (2011) 307-313; DOI:10.1016/j.ijpharm.2011.02.043.
7. Z. Mohammadi, F. A. Dorkoosh, S. Hosseinkhani, K. Gilani, T. Amini, A. Rouholamini Najafa-badi and M. Rafiee Tehrani, In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung, Int. J. Pharm. 421 (2011) 183-188; DOI: 10.1016/j.ijpharm.2011.09.029.
8. M. S. Muthu and S. Feng, Pharmaceutical stability aspects of nanomedicines, Nanomedicine 4 (2009) 857-860; DOI:10.2217/nnm.09.75.
9. International Conference on Harmonization, ICH Q1A (R2), Stability Testing Guidelines: Stability Testing of New Drug Substances and Products, ICH step 5, CPMP/ICH/2736/99, London 2003.
10. F. Romain, A. Laqueyrerie, P. Militzer, P. Pescher, P. Chavarot, M. La-Granderie, G. Auregan, M. Gheorghiu and G. Marchal, Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria, Infect. Immun 61 (1993) 742-750. (Pubitemid 23030868)
11. M. Elfinger, J. Geiger, G. Hasenpusch, S. Üzgün, N. Sieverling, M. K. Aneja, C. Maucksch and C. Rudolph, Targeting of the b2-adrenoceptor increases nonviral gene delivery to pulmonary epithelial cells in vitro and lungs in vivo, J. Control. Release 135 (2009) 234-241; DOI: 10.1016/j. jcourel.2009.01.012.
12. H. Mao, K. Roy, V. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August and K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Release 70 (2001) 399-421; DOI: 10.1016/s0168-3659(00)00361-8 (Pubitemid 32155463)
13. International Conference on Harmonization, ICH Q5C, Stability Testing of Biotechnological/Biolog-ical Products, ICH step 4, CPMP/ICH/138/95, London 1996.
14. T. Arakawa, S. J. Prestrelski, W. C. Kenney and J. F. Carpenter, Factors affecting short-term and long-term stabilities of proteins, Adv. Drug Deliver. Rev. 46 (2001) 307-326; DOI: 10.1016/s0169-409x(00)00144-7.
15. G. Borchard, Chitosans for gene delivery, Adv. Drug Deliver. Rev. 52 (2001) 145-150; DOI: 10.1016/s0169-409x(01)00198-3. (Pubitemid 33079170)
16. H. Okamoto, Y. Sakakura, K. Shiraki, K. Oka, S. Nishida, H. Todo, K. Iida and K. Danjo, Stability of chitosan-pDNA complex powder prepared by supercritical carbon dioxide process, Int. J. Pharm 290 (2005) 73-81; DOI: 10.1016/j.ijpharm.2004.11.026. (Pubitemid 40139046)
17. W. Walther, U. Stein, C. Voss, T. Schmidt, M. Schleef and P. M. Schlag, Stability analysis for long-term storage of naked DNA: impact on nonviral in vivo gene transfer, Anal. Biochem 318 (2003) 230-235; DOI: 10.1016/s0003- 2697(03)00244-6. (Pubitemid 36694114)
18. D. M. Prazeres, G. N. M. Ferreira, G. A. Monteiro, C. L. Cooney and J. M. S. Cabral, Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks, Trends Biotechnol. 17 (1999) 169-174; DOI: 10.1016/s0167-7799(98)01291-8. (Pubitemid 29273948)